Category: Leadership 3

Hui Tian, PhD

Dr. Hui Tian joined The Column Group in 2022 as a Venture Partner.  Previously he was a founding member of NGM Biopharmaceuticals and most recently served as Senior Vice President of Research.  In this role, he was responsible for discovery research across multiple therapeutic areas including metabolic diseases, retinal diseases and cancer.  In a span …

Hui Tian, PhD Read More »

Jeff Goater

Jeff Goater joined The Column Group as a Venture Partner in 2021. Previously, he served as Chief Executive Officer of Surface Oncology.  During his tenure at Surface, the company fostered an award-winning culture, advanced four programs into clinical development, completed its initial public offering and secured multiple strategic collaborations, including a transformative partnership with GlaxoSmithKline.  …

Jeff Goater Read More »

John Josey

John Josey, PhD

Dr. Josey joined The Column Group as a Venture Partner in 2020. Previously he served as the President, Chief Executive Officer and a member of the Board of Directors of Peloton Therapeutics, Inc., from 2013 until its acquisition by Merck in 2019. He joined Peloton in 2011 as the first employee in the role of …

John Josey, PhD Read More »

JJ Kang

JJ Kang, PhD

Dr. Kang joined The Column Group in 2015. Previously, Dr. Kang worked at FibroGen in the project management of drug discovery and development programs, and prior to that, in corporate strategy. Dr. Kang investigated inhibition of DNA methylation and chemical induction of immunogenicity in cancer cells in the laboratory of Professor Peter Dervan, completing her …

JJ Kang, PhD Read More »

Scroll to Top